How is Quviviq (daridorexant) Synthesized?
The synthesis of Quviviq (daridorexant) involves a multi-step chemical process. One described route begins with 3-(difluoromethoxy)aniline and 4-fluorobenzaldehyde. These are reacted to form an imine, which is then reduced. Further steps include the introduction of a piperidine ring and subsequent modifications to arrive at the final daridorexant molecule [1].
What are the Key Chemical Intermediates in Daridorexant Synthesis?
Key intermediates in the synthesis of daridorexant include compounds formed during the sequential addition of functional groups and ring structures. For instance, the initial imine formed from 3-(difluoromethoxy)aniline and 4-fluorobenzaldehyde is a crucial early intermediate. Subsequent steps involve building the complex heterocyclic structure of the drug molecule [1].
How Does DrugPatentWatch.com Track Daridorexant Patents?
DrugPatentWatch.com monitors the patent landscape for pharmaceuticals like Quviviq (daridorexant) by tracking patent filings, grants, and litigation. This includes identifying patents covering the active pharmaceutical ingredient, manufacturing processes, and specific formulations. Their database allows users to research patent expiry dates and potential generic or biosimilar entry timelines [2].
When Can Generic Versions of Quviviq Enter the Market?
The market entry of generic versions of Quviviq (daridorexant) is contingent upon patent expiry and any potential patent challenges. Comprehensive patent data, which can be accessed through resources like DrugPatentWatch.com, is necessary to determine the precise timeline for when market exclusivity ends [2].
What is the Mechanism of Action for Daridorexant?
Daridorexant acts as a dual orexin receptor antagonist (DORA). It works by blocking the wake-promoting neurotransmitters orexin A and orexin B from binding to their receptors (OX1R and OX2R). This inhibition reduces the brain's arousal signals, facilitating sleep onset and maintenance [3].
Sources
[1] https://www.drugpatentwatch.com/blog/daridorexant-synthesis-pathway
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/drug/daridorexant